消化酵素 Digestive Enzymes × 大腸激躁症
The totality of evidence supports a weak grade C for OTC digestive enzyme blends in irritable bowel syndrome.
The totality of evidence supports a weak grade C for OTC digestive enzyme blends in irritable bowel syndrome. Digestive Enzymes is absent from the Examine database (L1 coverage gap), so the grade rests on the downstream literature, which is thin and inconsistent: the only IBS-specific trials are small pilots (n=20-49, all rated low quality), the largest pancrealipase trial missed its primary endpoint (61% preference, p=0.078) with positive results confined to a post-hoc subgroup, the alpha-galactosidase RCT was outright negative, and a multi-ingredient blend trial cannot isolate any enzyme effect. The single consistent positive signal (PMID 19835990) reflects a ~6% subgroup of diarrhea-predominant IBS patients who actually have misdiagnosed exocrine pancreatic insufficiency, which is a distinct diagnosis rather than evidence of efficacy in true IBS. Neither the ACG (2021) nor the AGA IBS guidelines recommend digestive enzymes, and Mayo, Cleveland Clinic and Harvard all describe the evidence as limited or unsettled. A grade of C (not D) is warranted because there is no clear counter-evidence of harm and a small, biologically plausible subgroup signal exists; it falls short of B because no adequately powered RCT and no guideline endorsement support general use.
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.46
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
台灣社群討論腸躁症幾乎以益生菌、飲食調整與壓力管理為主；消化酵素多被歸類為脹氣／飯後消化用途，少有人專為腸躁症使用。零星提及酵素時，主流看法認為僅能緩解不適、無法解決病根。針對「消化酵素 × 腸躁症」此一組合的在地真實討論稀少，無明確社群共識。
無共識（針對腸躁症的消化酵素討論稀少；社群多用益生菌/飲食/壓力管理，零星提及酵素者多認為只能緩解不適、無助於病根）
- 可溶性纖維（如洋車前子 psyllium）
- 低 FODMAP 飲食
- 腸道導向心理治療（如認知行為治療）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-ibs-INT-digestive-enzymes-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "消化酵素能改善大腸激躁症",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}